Utah Medical Products (UTMD) Cash from Investing Activities (2010 - 2026)
Utah Medical Products' (UTMD) quarterly Cash from Investing Activities came in at -$130000.0 in Q1 2026, up 29.35% year-on-year from -$100504.2 in Q1 2025, and down 19.27% quarter-over-quarter from -$109000.0 in Q4 2025.
Utah Medical Products (UTMD) Cash from Investing Activities (2010 - 2026) Analysis & Trends
Utah Medical Products' Cash from Investing Activities history runs 17 years deep, the most recent figure standing at -$130000.0 for Q1 2026.
- On a quarterly basis, Cash from Investing Activities rose 29.35% year-over-year to -$130000.0 in Q1 2026; TTM through Mar 2026 was -$317000.0, a 20.15% increase from a year earlier, with the FY2025 full-year figure at -$371000.0, down 78.37% from the prior year.
- Cash from Investing Activities slipped to -$130000.0 in Q1 2026 per UTMD's latest filing, from -$109000.0 in the prior quarter.
- Across five years, Cash from Investing Activities topped out at $5000.0 in Q1 2024 and bottomed at -$321000.0 in Q3 2022.
- The 5-year median for Cash from Investing Activities is -$109000.0 (2025), against an average of -$127411.8.
- Across the five-year window, Cash from Investing Activities soared 111.63% in 2024 and plunged 3780.0% in 2025, its largest moves.
- Year by year, Cash from Investing Activities stood at -$38000.0 in 2022, then tumbled by 136.84% to -$90000.0 in 2023, then surged by 90.0% to -$9000.0 in 2024, then sank by 1111.11% to -$109000.0 in 2025, then fell by 19.27% to -$130000.0 in 2026.
- Per Business Quant, the three latest UTMD Cash from Investing Activities figures stand at -$130000.0 (Q1 2026), -$109000.0 (Q4 2025), and -$27000.0 (Q3 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 126.32 Bn | 121.10 Bn | 1.96 Bn | -26.60 Mn |
| 2 | Becton Dickinson | 44.69 Bn | 43.88 Bn | 2.15 Bn | -139.00 Mn |
| 3 | Alcon | 32.80 Bn | 31.14 Bn | 1.53 Bn | -218.00 Mn |
| 4 | Medline | 32.72 Bn | 30.49 Bn | 1.84 Bn | -96.00 Mn |
| 5 | Resmed | 29.54 Bn | 27.88 Bn | 890.98 Mn | -58.03 Mn |
| 6 | West Pharmaceutical Services | 23.56 Bn | 23.13 Bn | 329.20 Mn | -43.20 Mn |
| 7 | Solventum | 14.00 Bn | 13.44 Bn | 1.10 Bn | -77.00 Mn |
| 8 | Cooper Companies | 13.75 Bn | 13.61 Bn | 735.40 Mn | -90.00 Mn |
| 9 | Align Technology | 12.03 Bn | 10.97 Bn | 736.59 Mn | -131.58 Mn |
| 10 | Utah Medical Products | 222.95 Mn | 135.54 Mn | 5.28 Mn | -130,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -130,000.00 |
| Mar 31, 2026 | -130,000.00 |
| Dec 31, 2025 | -109,000.00 |
| Dec 31, 2025 | -109,000.00 |
| Sep 30, 2025 | -27,000.00 |
| Sep 30, 2025 | -27,000.00 |
| Jun 30, 2025 | -51,000.00 |
| Jun 30, 2025 | -51,000.00 |
| Mar 31, 2025 | -184,000.00 |
| Mar 31, 2025 | -184,000.00 |
| Dec 31, 2024 | -9,000.00 |
| Dec 31, 2024 | -9,000.00 |
| Sep 30, 2024 | -89,000.00 |
| Sep 30, 2024 | -89,000.00 |
| Jun 30, 2024 | -115,000.00 |
| Jun 30, 2024 | -115,000.00 |
| Mar 31, 2024 | 5,000.00 |
| Mar 31, 2024 | 5,000.00 |
| Dec 31, 2023 | -90,000.00 |
| Dec 31, 2023 | -90,000.00 |